Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | MS4A4A |
| Upstream (Parents) |
|---|
| (<<) C1QA → MS4A4A |
| (<<) MAFB → MS4A4A |
| (<<) C3AR1 → MS4A4A |
| Downstream (Children) |
|---|
| MS4A4A → EHMT2 (>>) |
| MS4A4A → CD72 (>>) |
| MS4A4A → WDR62 (>>) |
| MS4A4A → LY86 (>>) |
| MS4A4A → SP2 (>>) |
| MS4A4A → CD163 (>>) |
| MS4A4A → KIAA0495 (>>) |
| MS4A4A → C1QA (>>) |
| MS4A4A → C1QB (>>) |
| MS4A4A → CMKLR1 (>>) |
| MS4A4A → MRC1L1///MRC1 (>>) |
| MS4A4A → HMOX1 (>>) |
| MS4A4A → HSPA1B///HSPA1A (>>) |
| MS4A4A → FCGR2B (>>) |
| MS4A4A → CD38 (>>) |
| MS4A4A → CTSL1 (>>) |
| MS4A4A → NPL (>>) |
| MS4A4A → LAIR1 (>>) |
| MS4A4A → NCKAP1L (>>) |
| MS4A4A → MAFB (>>) |
| MS4A4A → C3AR1 (>>) |
| MS4A4A → SLC31A2 (>>) |
